AUSTIN — Surterra Texas announced Thursday it’s starting to sell marijuana-derived medicine in Texas almost a year after being licensed by the state. The company is the third and final to open under the state’s Compassionate Use Program, which lets patients treat intractable epilepsy with cannabidiol that’s low in THC, the component that gives users a high.
Knox Medical in Schulenburg and Compassionate Cultivation, in the Austin-area, both made their first sales in February.
"We are thrilled to offer epilepsy patients in Texas a compelling new treatment option through the launch of Surterra's first medical cannabis product in the state," Surterra CEO William "Beau" Wrigley, Jr. said in a statement.
